Company Pain Therapeutics, Inc. Nasdaq
Equities
US69562K5065
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 18-09-30 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 98-05-31 | |
Robert Cook
LAW | General Counsel | 60 | 22-09-30 |
Michael Marsman
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Robert Gussin
BRD | Director/Board Member | 86 | 03-02-28 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-06 |
Director/Board Member | 92 | 98-08-31 | |
Richard Barry
BRD | Director/Board Member | 65 | 21-06-10 |
Director/Board Member | 65 | 98-05-31 | |
Claude Nicaise
BRD | Director/Board Member | 71 | Dec. 06 |
Robert Anderson
BRD | Director/Board Member | 58 | Dec. 06 |
Pierre Gravier
BRD | Director/Board Member | 39 | Dec. 06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,245,758 | 40,141,808 ( 92.82 %) | 0 | 92.82 % |
Company contact information
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |